Thymic stromal lymphopoietin signaling in CD4+ T cells is required for TH2 memory - 05/03/15
Abstract |
Background |
Thymic stromal lymphopoietin (TSLP) is a key factor in the development of allergic asthma. Numbers of TH2 memory cells gradually increase in allergic patients with the progression of disease and persist in the lungs during remission, although the mechanism is not clear.
Objective |
We sought to define the role of TSLP in TH2 memory cell generation and maintenance in vivo.
Methods |
Adoptive transfer of wild-type and thymic stromal lymphopoietin receptor (TSLPR)–deficient ovalbumin-specific CD4+ T cells before TH2 sensitization was used to define T cell–specific TSLP effects. Atopic dermatitis and increased serum TSLP concentrations were induced by topical application of the vitamin D3 analog MC903. Memory cells in peripheral blood were monitored weekly with flow cytometry. Memory recall was tested after intranasal ovalbumin challenge.
Results |
TSLP signaling in CD4+ T cells is required for the generation/maintenance of memory cells after in vivo priming. TSLPR-deficient CD4+ T cells have no defects in proliferation but do not survive 1 week after sensitization, and increased TSLP expression during sensitization significantly increased the frequency of memory cells. Although in vitro–differentiated TSLPR-deficient TH2 cells develop into memory cells with equal efficiency to wild-type cells, the recall response to airway antigen challenge is impaired. Moreover, after antigen challenge of mice with established TH2 memory, TSLP signaling in CD4+ T cells significantly affects memory cell generation/maintenance from secondary effector cells.
Conclusion |
TSLP signaling in CD4+ T cells is required for not only TH2 memory cell formation in vivo but also the recall response of the memory cells to local antigen challenge.
Le texte complet de cet article est disponible en PDF.Key words : Thymic stromal lymphopoietin, TH2 memory, memory recall, allergic airway inflammation, eosinophilia
Abbreviations used : 7-AAD, APC, BAL, CD62L, CFSE, DC, IL-7Rα, medLN, OVA, TCR, Treg, TSLP, TSLPR, WT
Plan
Supported by the National Institutes of Health (grant AI085046 to B.Z.). Support was provided by the HB Wells Center was in part from the Riley Children's Foundation. |
|
Disclosure of potential conflict of interest: The authors have received research support from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. |
Vol 135 - N° 3
P. 781 - mars 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?